Lyra Therapeutics’ Partnership and License Agreement with LianBio

Martina Bellini
Tagged:

Goodwin Procter LLP advised Lyra Therapeutics, Inc. on the deal.Lyra Therapeutics, Inc. (Nasdaq: LYRA) announced its strategic partnership and exclusive license agreement with LianBio for the development…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here